Suppr超能文献

别嘌醇剂量选择:剂量与氧嘌呤醇血浆浓度、尿酸盐浓度及尿尿酸排泄之间的关系。

Allopurinol dosage selection: relationships between dose and plasma oxipurinol and urate concentrations and urinary urate excretion.

作者信息

Day R O, Miners J O, Birkett D J, Whitehead A, Naidoo D, Hayes J, Savdie E

机构信息

Department of Clinical Pharmacology, St Vincent's Hospital, Darlinghurst, Sydney, Australia.

出版信息

Br J Clin Pharmacol. 1988 Oct;26(4):423-8. doi: 10.1111/j.1365-2125.1988.tb03401.x.

Abstract
  1. Allopurinol usage in 50 patients of a city teaching hospital was surveyed. 2. The plasma concentrations of oxipurinol and uric acid and the urinary production of uric acid were examined. 3. The daily doses of allopurinol ranged from 50 to 1200 mg but 83% of patients were taking 300 mg daily. 4. A wide range of plasma oxipurinol concentrations was observed from 2.8 to 55.8 mg l-1 with a mean +/- s.d. of 15.2 +/- 11.7 mg l-1. 5. The population studied included a high proportion of patients with renal impairment and creatinine clearance was a significant determinant of oxipurinol concentrations (P less than 0.005). 6. There was no significant correlation between plasma urate and plasma oxipurinol concentrations and only a few plasma urates were above the upper limit of the reference range of the laboratory. 7. It was apparent that many patients were taking unnecessarily high daily doses of allopurinol and that renal status was not always considered when deciding dosage regimens of allopurinol.
摘要
  1. 对某城市教学医院的50例患者使用别嘌醇的情况进行了调查。2. 检测了氧嘌呤醇和尿酸的血浆浓度以及尿酸的尿生成量。3. 别嘌醇的日剂量范围为50至1200毫克,但83%的患者每日服用300毫克。4. 观察到血浆氧嘌呤醇浓度范围很广,为2.8至55.8毫克/升,平均±标准差为15.2±11.7毫克/升。5. 所研究的人群中肾功能损害患者比例较高,肌酐清除率是氧嘌呤醇浓度的一个重要决定因素(P<0.005)。6. 血浆尿酸盐与血浆氧嘌呤醇浓度之间无显著相关性,只有少数血浆尿酸盐高于实验室参考范围的上限。7. 显然,许多患者每日服用别嘌醇的剂量过高且不必要,在确定别嘌醇的给药方案时,肾功能状况并非总是被考虑在内。

相似文献

2
3
Dosage prescribing and plasma oxipurinol levels in patients receiving allopurinol therapy.
Eur J Clin Pharmacol. 1990;39(4):419-21. doi: 10.1007/BF00315424.

引用本文的文献

2
Honorary Professor Garry Graham.名誉教授加里·格雷厄姆。
Inflammopharmacology. 2021 Oct;29(5):1255-1259. doi: 10.1007/s10787-021-00872-1. Epub 2021 Sep 17.

本文引用的文献

3
Renal clearance of oxipurinol, the chief metabolite of allopurinol.
Am J Med. 1968 Jul;45(1):69-77. doi: 10.1016/0002-9343(68)90008-9.
5
6
Use and abuse of allopurinol.别嘌醇的使用与滥用
Br Med J (Clin Res Ed). 1987 Jun 13;294(6586):1504-5. doi: 10.1136/bmj.294.6586.1504.
7
Asymptomatic hyperuricaemia.无症状性高尿酸血症
Br Med J (Clin Res Ed). 1987 Apr 18;294(6578):987-8. doi: 10.1136/bmj.294.6578.987.
9
Inhibition of urate production by allopurinol.
Biochem Pharmacol. 1977 Mar 1;26(5):355-8. doi: 10.1016/0006-2952(77)90191-5.
10
High-performance liquid chromatographic assay for allopurinol and oxipurinol in human plasma.
J Chromatogr. 1979 Jan 1;162(1):94-7. doi: 10.1016/s0378-4347(00)82068-x.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验